Refused Medicines in Social Care – Should You Give Medicines Covertly?

Firstly, care staff should record any refusal of medicines on the person’s Medication Administration Record (MAR) or electronic MAR (eMAR), including the reason for refusal where possible. Accurate and timely record-keeping is essential, as NICE guidance highlights the importance of clear documentation and information-sharing in managing medicines safely in care homes.

Refusals should be monitored over time to identify patterns or recurring issues. If refusals are frequent, persistent, or place the person at risk of harm, care staff must escalate the concern. This usually involves requesting a medication review by the prescriber (like the GP) to consider alternatives, such as a different formulation, dosage, or medication that may be more acceptable or better tolerated.

Care workers should also explore and document possible reasons for refusal, which can include:

• Mental health conditions such as anxiety, depression or distress
• Cultural or religious beliefs affecting acceptance of medication
• Lack of understanding about what the medicine is for
• Communication barriers, including limited English, hearing or visual impairments
• Physical difficulties (for example swallowing problems)
• Side effects or previous negative experiences with medication

Understanding the reason for refusal supports a person-centred approach, which is a key expectation in CQC-regulated care.

In some cases, repeated refusal may indicate that a person lacks the mental capacity to make decisions about their medicines. Under the Mental Capacity Act 2005, capacity is decision-specific and must always be assessed before any decision is made on a person’s behalf.

Care staff must be alert to signs of a lack of capacity, such as confusion, inability to understand or retain information, or inability to weigh up the risks and benefits of taking medication. There should be a clear process in place for raising and responding to capacity concerns, and all staff should be trained to recognise these signs.

Step 1: Mental capacity assessment

If concerns are identified, a formal mental capacity assessment must be carried out by an appropriate professional (for example, the prescriber or another suitably trained practitioner). This assessment must follow the principles of the Mental Capacity Act and determine whether the person can:

• Understand relevant information
• Retain that information
• Use or weigh that information to make a decision
• Communicate their decision

All details of the assessment, including who carried it out, when, where, and the outcome, must be fully recorded and reflected in the person’s care plan.

Step 2: Best interests decision

If the person is assessed as lacking capacity, a best interests decision must be made before any covert administration is considered. This involves arranging a multi-disciplinary meeting, which may include:

• The prescriber
• Care staff and service managers
• A pharmacist
• Family members or informal carers
• A Health and Welfare Lasting Power of Attorney (if appointed)
• An Independent Mental Capacity Advocate (IMCA), where appropriate

The group must consider all options, including stopping the medication, offering it in a different form, or administering it covertly. The decision must be based on what is in the person’s best interests, taking into account their past and present wishes, values and beliefs.

It is also essential to check whether the individual has an advance decision to refuse treatment (ADRT) or any existing legal arrangements, as these must be respected under the law.

Step 3: Clear authorisation and documentation

Medicines must never be given covertly unless this has been formally agreed and documented following a best interests process. All decisions, attendees, and outcomes must be clearly recorded, and care plans updated immediately.

Care providers are expected to have a robust medicines policy, in line with NICE guidance, that includes clear procedures for covert administration, staff responsibilities, and governance arrangements.
 
All staff involved in a person’s care must be informed of any agreed covert medication plan to ensure safe and consistent practice.

Step 4: Safe administration

If covert administration is agreed, care staff must seek advice from a pharmacist to ensure the medicine can be safely altered, for example crushed or mixed with food or drink, without affecting its effectiveness.

There must also be safeguards in place to ensure that:

• The medicine is given in line with the agreed plan
• It is not accidentally consumed by another resident
• Accurate records are maintained for every dose

Covert medication must always be treated as a last resort and a time-limited intervention. Regular reviews are essential because a person’s capacity can change, and they may regain the ability to make their own decisions.

Care providers should:

• Review the person’s capacity at appropriate intervals
• Review the ongoing need for covert medication
• Ensure staff remain trained and competent
• Audit medication practices to ensure compliance with CQC standards

The CQC expects providers to demonstrate that medicines are managed safely, that people are involved in decisions wherever possible, and that restrictive practices such as covert administration are lawful, proportionate, and regularly reviewed.

Overall, covert medication can only be used lawfully, safely and ethically when all legal requirements under the Mental Capacity Act have been met, and when it is clearly in the person’s best interests.

Managing medication refusal and covert administration in care homes requires a careful balance of legal compliance, person-centred care, and robust processes. By following the Mental Capacity Act, maintaining accurate documentation, and involving the right professionals in decision-making, care providers can ensure that residents are treated with dignity while minimising risks to their health and wellbeing. Clear communication, thorough record-keeping, and ongoing reviews are essential to reducing medication errors and maintaining safe, consistent care practices across your service.

If you’re looking to strengthen your medication processes, Access Medication Management solutions can help. By digitising MAR charts, automating documentation, and providing real-time visibility of medication records, Access supports care teams to reduce medication errors, improve accuracy, and ensure compliance with CQC expectations.

With intuitive eMAR systems and built-in audit trails, your staff can spend less time on paperwork and more time delivering safe, high-quality care. Book a demo to find out how Access can help you take control of your medication management and improve outcomes across your service.